
                             SEQUENCE LISTING

<110>  Gubra
 
<120>  hAM15-52 analogues with improved amylin receptor (hAMY3R) potency

<130>  P1684PC00

<160>  392

<170>  Gubra patent tool v 1.0

<210>  1
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  1

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Lys Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Tyr 
        35             


<210>  2
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  2

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Ser Ser Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Thr Tyr 
        35         


<210>  3
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  3

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  4
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  4

Lys Cys Asn Thr Ala Thr Cys Thr Val Asp Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  5
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  5

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Asp Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  6
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  6

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Lys Gly Xaa 
        35             


<210>  7
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  7

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Ala Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  8
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  8

Lys Cys Asn Thr Ser Thr Cys Thr Val Ala Arg Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asn Lys Asp Lys Ala Gln Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  9
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  9

Arg Cys Asn Ala Ser Thr Cys Thr Val Asn Arg Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asn Lys Asp Lys Ala Gln Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  10
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  10

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  11
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  11

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Asn Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  12
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  12

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Lys Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  13
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  13

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Ala Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  14
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  14

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  15
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  15

Lys Cys Asn Thr Ser Thr Cys Thr Val Ala Arg Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asp Lys Asp Lys Ala Asn Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  16
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  16

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  17
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  17

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  18
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  18

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Pro 
        35             


<210>  19
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  19

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Pro Arg Thr Lys Val 
            20                  25                  30         


Gly Ser Asn Gly Tyr 
        35         


<210>  20
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  20

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  21
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  21

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Asn Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  22
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  22

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Thr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  23
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  23

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Ala Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  24
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  24

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Ala Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  25
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  25

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Ala Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  26
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  26

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Ala Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  27
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  27

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Ala Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  28
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  28

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Ala Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  29
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  29

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  30
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  30

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  31
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  31

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  32
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  32

Arg Cys Gln Thr Ser Thr Cys Thr Val Ala Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Ala Gln Tyr Thr Asp Lys Asp Lys Asp Gln Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Ser Xaa 
        35             


<210>  33
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  33

Arg Cys Gln Ala Ser Thr Cys Thr Val Ala Xaa Leu Ala Glu Gln Ile 
1               5                   10                  15     


Ala Gln Tyr Thr Asp Lys Asp Lys Asp Gln Val Ala Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  34
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  34

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  35
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  35

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Gln Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  36
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  36

Lys Cys Lys Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  37
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  37

Lys Cys Asn Thr Ala Thr Cys Thr Val Ala Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  38
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  38

Lys Cys Asn Thr Ala Thr Cys Thr Val Asn Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  39
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  39

Arg Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  40
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  40

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Lys Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  41
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  41

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Lys Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  42
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  42

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Ala Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  43
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  43

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Ala Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  44
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  44

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Tyr Asn 
            20                  25                  30         


Glu Gly Ser Asn Gly Xaa 
        35             


<210>  45
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  45

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  46
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  46

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  47
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  47

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Tyr Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  48
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  48

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Tyr Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  49
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  49

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  50
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  50

Lys Cys Asn Thr Ser Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  51
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  51

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  52
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  52

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Ala Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  53
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  53

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Ala Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  54
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  54

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  55
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  55

Lys Cys Asn Thr Ala Thr Cys Thr Val Glu Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  56
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  56

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Thr Tyr 
        35             


<210>  57
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  57

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Ser Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  58
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  58

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Ser Ser Thr Lys Val 
            20                  25                  30         


Gly Ser Asn Thr Tyr 
        35         


<210>  59
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  59

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Pro Ser Thr Lys Val 
            20                  25                  30         


Gly Ser Asn Gly Tyr 
        35         


<210>  60
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  60

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  61
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  61

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  62
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  62

Lys Cys Asn Thr Ser Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  63
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  63

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Ala 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  64
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  64

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Ala Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  65
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  65

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  66
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  66

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ser Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  67
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  67

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  68
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  68

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  69
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  69

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Ser Xaa 
        35             


<210>  70
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  70

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  71
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  71

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Tyr Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  72
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  72

Lys Cys Gln Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  73
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  73

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Gln 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  74
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  74

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Lys Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  75
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  75

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  76
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (14)..(14)
<223>  X = Aad (L-homoglutamic acid)

<220>
<221>  misc_feature
<222>  (22)..(22)
<223>  X = Sar (Sarcosine)

<220>
<221>  misc_feature
<222>  (24)..(24)
<223>  X = (NMe)I (N-methyl-L-isoleucine)

<220>
<221>  misc_feature
<222>  (35)..(35)
<223>  X = Hyp (L-hydroxyproline)

<400>  76

Arg Cys Gly Thr Ala Thr Cys Ala Thr Glu Arg Leu Ala Xaa Phe Leu 
1               5                   10                  15     


Gln Arg Ser Ser Phe Xaa Ala Xaa Leu Ser Ser Thr Glu Val Gly Ser 
            20                  25                  30         


Asn Thr Xaa 
        35 


<210>  77
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  77

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  78
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  78

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  79
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  79

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Ser Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  80
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (22)..(22)
<223>  X = Sar (Sarcosine)

<220>
<221>  misc_feature
<222>  (24)..(24)
<223>  X = (NMe)I (N-methyl-L-isoleucine)

<220>
<221>  misc_feature
<222>  (35)..(35)
<223>  X = Hyp (L-hydroxyproline)

<400>  80

Arg Cys Gln Thr Ala Thr Cys Ala Thr Glu Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Gln Arg Ser Ser Phe Xaa Ala Xaa Leu Ser Ser Thr Glu Val Gly Ser 
            20                  25                  30         


Asn Thr Xaa 
        35 


<210>  81
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  81

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  82
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  82

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  83
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  83

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Ala Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  84
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  84

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Asn Gly Tyr 
        35             


<210>  85
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  85

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Val Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  86
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  86

Lys Cys Asn Thr Ala Thr Cys Thr Val Ala Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Asn Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  87
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  87

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asn Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  88
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  88

Lys Cys Asn Thr Ser Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Pro Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  89
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  89

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Lys Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  90
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  90

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Asn Gly Xaa 
        35             


<210>  91
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  91

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asn Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  92
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  92

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Pro Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  93
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  93

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Ala Pro Ser Thr Lys Val 
            20                  25                  30         


Gly Ser Asn Gly Tyr 
        35         


<210>  94
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  94

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Tyr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  95
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  95

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  96
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  96

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Thr Xaa 
        35             


<210>  97
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  97

Lys Cys Ala Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  98
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  98

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Tyr 
        35             


<210>  99
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  99

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  100
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  100

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Gln Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  101
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  101

Lys Cys Asn Ala Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  102
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  102

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  103
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  103

Lys Cys Asn Thr Ala Thr Cys Thr Val Val Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  104
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  104

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Tyr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  105
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  105

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Ala Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  106
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  106

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Ala Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  107
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  107

Lys Cys Asn Thr Ala Thr Cys Thr Val Ala Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  108
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  108

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Ala Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  109
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  109

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  110
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  110

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Glu Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  111
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  111

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  112
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  112

Lys Cys Asn Thr Ala Thr Cys Thr Val Asp Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  113
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  113

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Asn Gly Xaa 
        35             


<210>  114
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  114

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Ala Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  115
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  115

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  116
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  116

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  117
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  117

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  118
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  118

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  119
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  X = AIB (L-2-aminoisobutyric acid)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  119

Lys Cys Asn Thr Xaa Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  120
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  120

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Pro Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Ser Xaa 
        35             


<210>  121
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  121

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  122
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  122

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Ala Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  123
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  123

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Gly Ala Ile Ala Pro Arg Thr Lys Ile 
            20                  25                  30         


Gly Ser Gln Gly Tyr 
        35         


<210>  124
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  124

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  125
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  125

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  126
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  126

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  127
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  127

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  128
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  128

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Ala Pro Ser Thr Lys Ile 
            20                  25                  30         


Gly Pro Asn Gly Tyr 
        35         


<210>  129
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  129

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  130
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  130

Lys Cys Asn Thr Ala Thr Cys Thr Val Asp Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Pro Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  131
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  131

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  132
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  132

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  133
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  133

Lys Cys Asn Thr Ala Thr Cys Thr Val Ala Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Pro Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  134
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  134

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  135
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  135

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  136
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  136

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Lys Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  137
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  137

Lys Cys Asn Thr Ala Thr Cys Thr Val Ala Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Asn Gln Phe Thr Asp Lys Asp Lys Asp Pro Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  138
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  138

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  139
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  139

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Asn Gly Xaa 
        35             


<210>  140
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  140

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Ser Pro Gln Gly Tyr 
        35             


<210>  141
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  141

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  142
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  142

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Asn Gly Tyr 
        35             


<210>  143
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  143

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  144
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  144

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Pro Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  145
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  145

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  146
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  146

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  147
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  147

Gly Cys Arg Ile Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  148
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  148

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Ser Ser Thr Lys Ile 
            20                  25                  30         


Gly Ser Asn Gly Tyr 
        35         


<210>  149
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  149

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Pro Ser Thr Lys Val 
            20                  25                  30         


Gly Pro Asn Gly Tyr 
        35         


<210>  150
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  150

Gly Cys Arg Trp Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  151
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  151

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  152
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  152

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  153
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  153

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala Glu Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  154
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  154

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Tyr 
        35             


<210>  155
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  155

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  156
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  156

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  157
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  157

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  158
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  158

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  159
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  159

Lys Cys Asn Thr Ala Thr Cys Thr Val Ile Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  160
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  160

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  161
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  161

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  162
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  162

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Pro Ser Thr Lys Ile 
            20                  25                  30         


Gly Pro Asn Gly Tyr 
        35         


<210>  163
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  163

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  164
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  164

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Tyr 
        35             


<210>  165
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  165

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  166
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  166

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  167
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  167

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  168
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  168

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  169
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  169

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  170
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  170

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Ser Pro Asn Gly Xaa 
        35             


<210>  171
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  171

Gly Cys Arg Trp Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  172
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  172

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Tyr 
        35             


<210>  173
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  173

Gly Cys Arg Met Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  174
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  174

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  175
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  175

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  176
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  176

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  177
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  177

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Asn Gly Tyr 
        35             


<210>  178
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  178

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  179
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  179

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  180
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  180

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Pro Ser Thr Lys Ile 
            20                  25                  30         


Gly Ser Asn Thr Tyr 
        35         


<210>  181
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  181

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  182
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  182

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Ser Pro Gln Gly Tyr 
        35             


<210>  183
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  183

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  184
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  184

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Trp 
        35             


<210>  185
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  185

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Trp Xaa 
        35             


<210>  186
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  186

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Tyr Xaa 
        35             


<210>  187
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  187

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  188
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  188

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Ser Pro Asn Gly Tyr 
        35             


<210>  189
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  189

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  190
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  190

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Asn Gly Tyr 
        35             


<210>  191
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  191

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  192
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  192

Gly Cys Arg Met Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  193
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  193

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


His Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  194
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  194

Lys Cys Arg Met Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  195
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  195

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  196
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  196

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  197
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  197

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Asn Gly Xaa 
        35             


<210>  198
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  198

Gly Cys Arg Ile Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  199
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  199

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Ser Pro Gln Gly Tyr 
        35             


<210>  200
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  200

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  201
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  201

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln His Xaa 
        35             


<210>  202
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  202

Gly Cys Arg Trp Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Ser Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  203
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  203

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Pro Xaa 
        35             


<210>  204
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  204

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  205
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  205

Lys Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  206
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  206

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Lys Xaa 
        35             


<210>  207
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  207

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Pro Ser Thr Lys Ile 
            20                  25                  30         


Gly Ser Asn Gly Tyr 
        35         


<210>  208
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  208

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Thr Tyr 
        35             


<210>  209
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  209

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  210
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  210

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ala 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  211
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  211

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Phe Xaa 
        35             


<210>  212
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  212

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  213
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  213

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Trp Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  214
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  214

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  215
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  215

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Met 
        35             


<210>  216
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  216

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  217
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  217

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  218
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  218

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Ala Xaa 
        35             


<210>  219
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  219

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln His Xaa 
        35             


<210>  220
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  220

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Trp Xaa 
        35             


<210>  221
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  221

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  222
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  222

Gly Cys Arg Met Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Ser Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  223
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  223

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  224
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  224

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  225
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  225

Lys Cys Asn Thr Leu Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  226
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  226

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Trp 
        35             


<210>  227
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  227

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


His Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  228
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  228

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


His Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  229
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  229

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  230
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  230

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Tyr 
        35             


<210>  231
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  231

Lys Cys Asn Thr Tyr Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  232
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  232

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Gln Xaa 
        35             


<210>  233
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  233

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Arg Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  234
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  234

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Tyr 
        35             


<210>  235
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  235

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Pro 
        35             


<210>  236
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  236

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Met Xaa 
        35             


<210>  237
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  237

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Met 
        35             


<210>  238
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  238

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Phe Xaa 
        35             


<210>  239
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  239

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Phe 
        35             


<210>  240
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  240

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Ser Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  241
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  241

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Ala 
        35             


<210>  242
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  242

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asn Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Arg 
        35             


<210>  243
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  243

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala Ala Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  244
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  244

Lys Cys Asn Thr Ser Thr Cys Thr Val Ala Xaa Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asn Lys Asp Lys Ala Gln Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  245
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  245

Arg Cys Asn Ala Ser Thr Cys Thr Val Asn Xaa Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asn Lys Asp Lys Ala Gln Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  246
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  246

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  247
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  247

Lys Cys Asn Thr Ser Thr Cys Thr Val Ala Xaa Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asp Lys Asp Lys Ala Asn Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  248
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  248

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  249
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  249

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Ala Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  250
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  250

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Ala Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  251
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  251

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Ala Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  252
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  252

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Ala Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  253
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  253

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  254
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  254

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  255
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  255

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  256
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  256

Arg Cys Gln Thr Ser Thr Cys Thr Val Ala Xaa Leu Ala Glu Gln Ile 
1               5                   10                  15     


Ala Gln Tyr Thr Asp Lys Asp Lys Asp Gln Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Ser Xaa 
        35             


<210>  257
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  257

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  258
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  258

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Ala Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  259
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  259

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  260
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  260

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  261
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  261

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  262
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  262

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Ala Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  263
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  263

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  264
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  264

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Thr Tyr 
        35             


<210>  265
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  265

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  266
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  266

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ser Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  267
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  267

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  268
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  268

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  269
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  269

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Asn Gly Tyr 
        35             


<210>  270
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  270

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Asn Gly Xaa 
        35             


<210>  271
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  271

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Tyr 
        35             


<210>  272
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  272

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  273
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  273

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  274
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  274

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  275
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  275

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Asn Gly Xaa 
        35             


<210>  276
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  276

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Ala Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  277
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  277

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  278
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  278

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  279
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  279

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  280
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  280

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  281
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  281

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  282
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  282

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Gly Ala Ile Ala Pro Arg Thr Lys Ile 
            20                  25                  30         


Gly Ser Gln Gly Tyr 
        35         


<210>  283
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  283

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  284
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  284

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  285
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  285

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  286
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  286

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  287
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  287

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  288
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  288

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  289
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  289

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  290
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  290

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Asn Gly Xaa 
        35             


<210>  291
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  291

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  292
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  292

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  293
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  293

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  294
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  294

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  295
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  295

Gly Cys Arg Ile Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  296
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  296

Gly Cys Arg Trp Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  297
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  297

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  298
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<400>  298

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  299
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  299

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  300
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  300

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  301
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  301

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  302
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  302

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  303
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  303

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  304
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  304

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  305
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X = Cit (L-citrulline)

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  305

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Xaa Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Ser Pro Gln Gly Xaa 
        35             


<210>  306
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  306

Lys Cys Asn Thr Ser Thr Cys Thr Val Ala Trp Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asn Lys Asp Lys Ala Gln Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  307
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  307

Arg Cys Asn Ala Ser Thr Cys Thr Val Asn Trp Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asn Lys Asp Lys Ala Gln Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  308
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  308

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Ala Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  309
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  309

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Ala Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  310
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  310

Lys Cys Asn Thr Ser Thr Cys Thr Val Ala Trp Leu Ala Asp Gln Ile 
1               5                   10                  15     


Thr Gln Phe Ser Asp Lys Asp Lys Ala Asn Val Ser Pro Pro Thr Glu 
            20                  25                  30         


Val Gly Pro Asn Ser Xaa 
        35             


<210>  311
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  311

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala Asn Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  312
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  312

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  313
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  313

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Ala Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  314
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  314

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Ala Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  315
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  315

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Ala Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  316
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  316

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Ala Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  317
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  317

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  318
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  318

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  319
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  319

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  320
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  320

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Ala Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  321
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  321

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Tyr Asn 
            20                  25                  30         


Glu Gly Ser Asn Gly Xaa 
        35             


<210>  322
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  322

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  323
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  323

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  324
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  324

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Ala Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  325
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  325

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Ala Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  326
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  326

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  327
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  327

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Thr Tyr 
        35             


<210>  328
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  328

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Ala Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  329
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (37)..(37)
<223>  X = Hyp (L-hydroxyproline)

<400>  329

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn Val 
            20                  25                  30         


Gly Ser Asn Gly Xaa 
        35         


<210>  330
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  330

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  331
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  331

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  332
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  332

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Asn Gly Tyr 
        35             


<210>  333
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  333

Lys Cys Asn Ala Ala Thr Cys Thr Val Gln Trp Leu Ala Glu Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  334
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  334

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  335
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  335

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  336
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  336

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  337
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  337

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Asn Gly Xaa 
        35             


<210>  338
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  338

Lys Cys Asn Thr Ala Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Ala Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Pro Thr Asn 
            20                  25                  30         


Val Gly Ser Asn Gly Xaa 
        35             


<210>  339
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  339

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  340
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  340

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  341
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  341

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  342
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  342

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  343
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  343

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  344
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  344

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  345
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  345

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Gln Gly Tyr 
        35             


<210>  346
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  346

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  347
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  347

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Asn Gly Xaa 
        35             


<210>  348
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  348

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Asn Gly Tyr 
        35             


<210>  349
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  349

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  350
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  350

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Gln Gly Xaa 
        35             


<210>  351
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  351

Gly Cys Arg Ile Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Phe Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Ser Pro Gln Thr Xaa 
        35             


<210>  352
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  352

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  353
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  353

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Xaa 
        35             


<210>  354
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  354

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  355
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  355

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Xaa 
        35             


<210>  356
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  356

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  357
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  357

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  358
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  358

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  359
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  359

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Xaa 
        35             


<210>  360
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide

<220>
<221>  misc_feature
<222>  (38)..(38)
<223>  X = Hyp (L-hydroxyproline)

<400>  360

Gly Cys Arg Thr Gly Thr Cys Thr Val Gln Trp Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Ser Pro Asn Gly Xaa 
        35             


<210>  361
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  361

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  362
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  362

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  363
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  363

Lys Cys Asn Phe Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  364
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  364

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  365
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  365

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  366
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  366

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Ser Pro Asn Gly Tyr 
        35             


<210>  367
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  367

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Asn Gly Tyr 
        35             


<210>  368
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  368

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  369
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  369

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  370
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  370

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Glu 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  371
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  371

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Ser Pro Asn Gly Tyr 
        35             


<210>  372
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  372

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala Asn Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  373
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  373

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Asn Gly Tyr 
        35             


<210>  374
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  374

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  375
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  375

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  376
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  376

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Ser Asn Gly Tyr 
        35             


<210>  377
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  377

Gly Cys Arg Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  378
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  378

Lys Cys Asn Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Ser Asn Gly Tyr 
        35             


<210>  379
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  379

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  380
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  380

Gly Cys Arg Phe Ala Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  381
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  381

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Asn Gly Tyr 
        35             


<210>  382
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  382

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  383
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  383

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Asn 
            20                  25                  30         


Ile Ser Pro Asn Gly Tyr 
        35             


<210>  384
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  384

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Val Ser Pro Asn Gly Tyr 
        35             


<210>  385
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  385

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Ser Pro Asn Gly Tyr 
        35             


<210>  386
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  386

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


<210>  387
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  387

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  388
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  388

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Asn 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  389
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  389

Lys Cys Asn Phe Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15     


Val Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Ser Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  390
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  390

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  391
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  391

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Gln Ile 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Ile Gly Pro Gln Gly Tyr 
        35             


<210>  392
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed polypeptide


<400>  392

Gly Cys Arg Phe Gly Thr Cys Thr Val Gln Arg Leu Ala His Phe Leu 
1               5                   10                  15     


Tyr Gln Phe Thr Asp Lys Asp Lys Asp Asn Val Ala Pro Arg Thr Lys 
            20                  25                  30         


Val Gly Pro Gln Gly Tyr 
        35             


